Internal Medicine, Interventional Cardiology · Baton Rouge, LA
NPI
1780990838
Since 2010
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8401 Picardy Ave
Baton Rouge, LA, 70809
Phone (225) 308-0247
Groups this clinician bills Medicare through
Medicare paid, 2024
$269K
3,672 services
Medicare patients, 2024
662
Average age 73
Drug cost, 2024
$1.4M
12,218 prescriptions
Company payments, 2025
$3,442
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit N Patel was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 578 times for 343 patients. In total Amit N Patel billed 3,672 services in 104 codes, and Medicare paid $269K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 578 | 343 | $12.39 | $7,159 |
| 99214 Office E&M - Established | Office | 519 | 325 | $86.54 | $45K |
| 93000 Electrocardiogram | Office | 323 | 291 | $10.32 | $3,335 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 288 | 72 | $4.14 | $1,193 |
| 93010 Electrocardiogram | Facility | 195 | 149 | $6.51 | $1,270 |
| 80061 Clinical Chemistry | Office | 167 | 150 | $13.02 | $2,174 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 130 | 12 | $44.91 | $5,839 |
| 93306 Echocardiography (TTE/TEE) | Office | 120 | 120 | $135.48 | $16K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 113 | 11 | $46.39 | $5,243 |
| 80053 Clinical Chemistry | Office | 104 | 102 | $10.29 | $1,070 |
| 99213 Office E&M - Established | Office | 88 | 80 | $65.98 | $5,807 |
| 80048 Clinical Chemistry | Office | 80 | 67 | $8.29 | $663 |
| 84450 Clinical Chemistry | Office | 55 | 49 | $5.08 | $279 |
| 84460 Clinical Chemistry | Office | 54 | 48 | $5.19 | $280 |
| 93016 Electrocardiogram | Office | 47 | 47 | $15.88 | $746 |
By year: 2022 $305K for 4,354 services; 2023 $310K for 4,598 services; 2024 $269K for 3,672 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 167 | 150 | $13.02 | $2,174 |
| 80053 Clinical Chemistry | 104 | 102 | $10.29 | $1,070 |
| 80048 Clinical Chemistry | 80 | 67 | $8.29 | $663 |
| 84450 Clinical Chemistry | 55 | 49 | $5.08 | $279 |
| 84460 Clinical Chemistry | 54 | 48 | $5.19 | $280 |
| 84075 Clinical Chemistry | 38 | 38 | $5.08 | $193 |
| 85027 Blood Count | 21 | 19 | $6.34 | $133 |
| 83036 Blood Count | 13 | 13 | $9.52 | $124 |
| 84443 Clinical Chemistry | 11 | 11 | $16.46 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Amit N Patel prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,192 prescriptions and refills. In total Amit N Patel wrote 12,218 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,192 | 3,308 | 388 | $9,502 |
| Amlodipine Besylate Generic | 866 | 2,291 | 268 | $4,523 |
| Rosuvastatin Calcium Generic | 807 | 2,157 | 252 | $11K |
| Carvedilol Generic | 734 | 1,928 | 221 | $5,141 |
| Furosemide Generic | 709 | 1,589 | 220 | $2,595 |
| Metoprolol Succinate Generic | 680 | 1,772 | 202 | $7,481 |
| Clopidogrel Clopidogrel Bisulfate | 679 | 1,846 | 216 | $6,388 |
| Potassium Chloride Generic | 537 | 1,213 | 180 | $7,163 |
| Eliquis Apixaban | 530 | 956 | 117 | $543K |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 405 | 1,041 | 135 | $15K |
| Metoprolol Tartrate Generic | 332 | 818 | 102 | $1,940 |
| Valsartan Generic | 270 | 721 | 91 | $6,837 |
| Nebivolol Hcl Generic | 250 | 602 | 74 | $21K |
| Lisinopril Generic | 250 | 703 | 80 | $1,429 |
| Hydralazine Hcl Generic | 216 | 490 | 62 | $2,958 |
Brand drugs: - claims; generic drugs: 10,780 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit N Patel $3,442 ($3,442 in general payments such as food, travel and fees) from 15 companies. The largest payer was AngioDynamics, Inc. with $2,400.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 1 | $2,400 |
| Medtronic, Inc. MDT | 10 | $552 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $80.3 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $61.4 |
| Abiomed JNJ | 2 | $53.85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $53.61 |
| Boston Scientific Corporation BSX | 2 | $52.27 |
| Kestra Medical Technology Services, Inc. | 2 | $37.98 |
| Bard Peripheral Vascular, Inc. BDX | 1 | $31.08 |
| Penumbra, Inc. PEN | 1 | $27.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.